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Sumrrlary 
A cytotoxic T  lymphocyte (CTL) line, derived from the liver of a common chimpanzee (Pan 
troglodytes)  with hepatitis C,  specifically recognized a hepatitis C  viral 9-mer peptide  (KHP- 
DATYSIL in single-letter amino acid code) bound by the major histocompatibility complex 
(MHC) class I molecule, Patr-A04. This same CTL line also recognized the identical peptide 
bound by a structurally different class I molecule, Papa-A06, derived from the separate chim- 
panzee species,  Pan paniscus or pygmy chimpanzee. These class I allotypes differ by six amino 
acids but, in spite of the structural differences, share the same antigen-presenting function. This 
is the first observation of antigen presentation to a given T  cell receptor by different MHC class 
I allotypes from separate species. 
M 
HC  class I  alleles  have been identified in  all major 
classes of vertebrate species, and sequence compari- 
son indicates that remarkable diversification has  occurred. 
African apes and man share probably orthologous class I A, 
B,  and  C  loci  (1-3).  Although  no  identical  alleles  have 
been found between species, comparison of human (HLA), 
common  chimpanzee  (Patr),  pygmy  chimpanzee  (Papa), 
and gorilla (Gogo)  (this  MHC nomenclature derives from 
the taxonomic names for the respective ape species:  the Pan 
troglodytes,  Pan paniscus,  and  G___oorilla  gorilla  [4]) class I genes 
indicates  no  species-defining  polymorphisms  (1,  2).  This 
suggests  that  much  of the  contemporary pattern  of poly- 
morphism  was  established  before  divergence  from  the 
common ancestor 5-7 million years ago. Crystal structures 
of class I molecules (5) indicated that most of the polymor- 
phism is concentrated at amino acid positions that interact 
with bound peptides and/or TC/L (6).  It seems clear that 
this aspect of the polymorphism has probably arisen by pos- 
itive Darwinian selection (7). The great structural similarity 
between MHC  class I  (and class II)  genes in these species 
partially vindicates  a  transspecies  mode  of evolution, first 
postulated by Klein (8). This encouraged us to explore the 
possibility that class I allotypes from different great ape spe- 
cies might present antigen across species barriers. 
In  the course of developing a potential vaccine against 
hepatitis C  virus  (HCV),  common chimpanzees were in- 
fected with HCV, and a panel of CD8 § CTL lines was de- 
veloped from liver biopsy samples  (9). We have identified 
class I molecules from this group of chimpanzees, together 
with  specific HCV-derived epitopes  that  they present  to 
individual  CTL  lines  (Kowalski,  H.,  A.L.  Erickson,  S. 
Cooper,  J.D.  Domena,  P.  Parham,  and  C.M.  Walker, 
manuscript in preparation). This defined system enabled us 
to investigate the possibility of cross-species antigen presen- 
tation by class I allotypes. It was logical to initially test this 
proposition with the most closely related species, Pan panis- 
cus. The precise phylogenetic position of the pygmy chim- 
panzee (also called bonobo) remains unresolved. However, 
there is an overwhelming view, based on comparative cra- 
nial and postcranial anatomy,  geographical separation,  so- 
cial  structure  and  behavior,  and  genetic  divergence  (10) 
that  the  common  chimpanzee,  Pan  troglodytes,  and  the 
pygmy chimpanzee,  P. paniscus,  are  separate  species,  with 
an estimated divergence time of 2.0 +  0.5 million yr (11). 
Materials  and Methods 
Animal Challenge Protocol.  Vaccination  with HCV envelope 
antigens and subsequent intravenous challenge with HCV-1/910 
is described elsewhere (9). 
Cell Lines.  CTL and  B  cell lines were  derived  from two 
chimpanzees, [Loss (Ch-503) and Blair (Ch-458), housed at Lab- 
oratory  for  Experimental  Medicine  and  Surgery  in  Primates 
(LEMSIP)  (New  York  University  Medical  Center,  Tuxedo, 
NY), and B cell lines were derived from 10 pygmy chimpanzees 
housed at Yerkes Regional Primate Center (Atlanta, GA). To es- 
tablish  B  lymphoblastoid  cell lines (BLCL), ape  PBMC  were 
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and  503/10D  were  obtained by limiting  dilution  culture  from 
liver biopsy samples taken from Ross and Blair.  Cells were in- 
duced  to  proliferate  with  anti-CD3  antibodies  (Immunotech, 
Westbrook, ME) and irradiated  human PBMC feeder cells in me- 
dium containing IL-2. This procedure is described  elsewhere  (9). 
Complementary DNA encoding ape MHC class I molecules was 
transfected  into  the  class I-negative mutant  human B  cell  line 
721.221  by using the stable  integrating vector pBJlneo,  as de- 
cribed  elsewhere  (12). Cell  surface  class I  expression  was  con- 
firmed by flow cytometry (Becton Dickinson & Co., Mountain 
View, CA), using the fluorescently  labeled  class I monomorphic 
mAb W6/32. Those transfectants  with highest class I expression 
were sorted by FACS  |  and expanded for experimental use. 
Peptides.  All  peptides  were  synthesized  by  either  Chiron 
Mimotopes  (Clayton, Victoria,  Australia)  or Research  Genetics 
(Huntsville,  AL)  using Fmoc solid-phase  methods.  All peptides 
have free NH  2 and COOH termini. 
CTL Assays.  Standard  51Cr release CTL assays were under- 
taken as described  (9). Results  are expressed  as the percentage of 
specific lysis. 
Identification  and  Isolation  of  Ape  MHC  Class  I  Molecules. 
Class I molecules were immunoprecipitated from both BLCL and 
the single-allele 721.221  transfectants,  using mAb W6/32. Class I 
heavy chains were subjected to one-dimensional isoelectric focus- 
ing (1D-IEF) analysis according to the protocol described  (13). 
P,.NA was extracted from 25 million BLCL, using the P,  NAzol  | 
method, followed by first strand cDNA synthesis and Patr-A, -B, 
and -C locus-specific PCR. amplification.  The same primers  and 
amplification  conditions were used as described  for HLA-A, -B, 
and -C-specific amplification  and sequencing (14).  The respec- 
tive  amplification  products were cloned into the single-stranded 
sequencing vector M13  and sequenced as described  (15). Data 
were  analyzed  using  GCG  8.1  software  (Genetics  Computer 
Group,  Inc., Madison,  WI)  (15) on a VAX 4000-90 computer 
(Digital, Maynard, MA). 
Results  and  Discussion 
The panel  of common chimpanzee-derived  CTL lines, 
recognizing common chimpanzee BLCL in the presence of 
well-characterized HCV-derived peptide epitopes,  enabled 
us to explore potential species cross-reactivities by class I al- 
lotypes. B  cell lines were therefore established from captive 
pygmy chimpanzees  (P. paniscus),  the  most closely related 
species  to  P.  troglodytes,  and  tested  against  the  common 
chimpanzee CTL panel.  5 CTL lines were tested against 10 
pygmy chimpanzee BLCL in the presence  and  absence of 
synthetic  peptides  (the  BLCL  derived  from  one  pygmy 
chimpanzee, Lord, was of low viability and not included in 
the CTL assays).  In these experiments,  there were two ex- 
amples of cross-species presentation.  The cell line from the 
pygmy chimpanzee Laura was lysed by CTL line 503/10D, 
but  only when  pulsed  with  the  highest  concentration  of 
peptide p189.2a (GDFDSVIDC)  (Fig.  1). Additionally, the 
Kidogo BLCL were lysed by CTL line 503/11.3  (Table  1), 
but in contrast,  the  degree of lysis  was comparable to that 
obtained with susceptible autologous common chimpanzee 
BLCL  targets.  Moreover,  this  result  with  Kidogo  BLCL 
was reproducible and titratable over the same range of pep- 
fide  concentrations  required  to  sensitize  the  common 
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Figure 1.  CTL assay using CTL line 503/10 D against Laura (P. Panis- 
cus) and Ross (P. troglodytes) BLCL targets. BLCL targets from common 
chimpanzee Ross ([3) and pygmy chimpanzee Laura (Q) were incubated 
for 1 h with the indicated concentration ofp189.2  (GDFDSVIDC) dur- 
ing labeling with 50 ~Ci of SlCr. Targets were incubated at an E/T ratio 
of 20:1 with CTL line 503/10 D derived from the liver of P,  oss as de- 
scribed (9). 
chimpanzee BLCL (Fig. 2). We (Kowalski, H., et al., manu- 
script in preparation)  had already established that CTL line 
503/11.3  recognized  an  HCV-derived  9-mer  peptide, 
KHPDATYSR (p206bc), presented by the common chim- 
panzee class I molecule Patr-A04, first sequenced by Mayer 
et al.  (3). Because of this striking result, further experiments 
were  designed  to  characterize  the  Kidogo  class  I  allotype 
responsible for presentation of the HCV peptide p206bc. 
1D-IEF  analysis  of immunoprecipitated  class  I  heavy 
chain bands from 11 pygmy chimpanzee cell lines and from 
2  Patr-A04-expressing  common  chimpanzee  cell  lines 
(Ross and Blair)  (Fig.  3)  indicated that  (a)  the Kidogo cell 
line  did  not  possess  a  heavy  chain  band  that  comigrated 
with  Patr-A04;  and  (b)  Kidogo  possessed  a  unique  band 
(Kidogo AI) compared with the other pygmy chimpanzee 
cell lines. 
To  identify  the  Papa  class  I  molecule  responsible  for 
binding and presenting p206bc,  full length  cDNA clones, 
representing  MHC  class  I-A, -B,  and  -C  alleles  from the 
Kidogo  cell  line,  were  isolated,  cloned,  and  sequenced. 
The  same  primers  and  amplification  conditions  used  for 
HLA-A, -B, and -C-specific amplification and sequencing 
were used without modification (14), emphasizing the high 
homology of both flanking and coding sequences between 
chimpanzee species and man. This resulted in the identifi- 
cation of two Papa-A (Kidogo A1,1 A2), one Papa-B  (Ki- 
dogo B1), and one Papa-C allele  (Kidogo C1).  These four 
1 In identifYing the Kidogo A locus DNA sequences we defined new 
Papa-A alleles. These have been assigned the names Papa-A06 and Papa- 
A07, respectively. KidogoA1 and Papa-A06 are used interchangeably in 
the text. 
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flora P. troglodytes 
Percent lysis of targets* 
Targets*  p206bc  1~  2  3 
Blair (Patr) 
+ 
Ross (Patr) 
+ 
Panbanisha 
+ 
Brian 
+ 
Zalia 
+ 
Kidogo 
+ 
Kanzi 
+ 
Jill 
+ 
Matata 
+ 
Kitty 
+ 
Laura 
+ 
Bosondjo 
+ 
<1 
98 
<1 
96 
<1 
6 
<1 
<1 
6 
11 
<1 
81 
3 
15 
<1 
60 
<1 
96 
<1 
<1 
<1 
<1 
<1 
3 
3 
6 
<1 
<1 
3 
79 
4 
93 
<1 
2 
*Values given represent the percentage of specific 5~Cr release after in- 
cubation with CTL hne 503/11.3 at an E/T ratio of  20:1 in a 4-h assay. 
1Leactions judged positive are given in boldface. Both Ross and Blair 
cell lines possess the Patr-A04 allele and are lysed. The only pygmy 
chimpanzee cell line presenting p206bc is Kidogo. 
*BLCL targets were pulsed with  10 I~m synthetic peptide p206bc for 
1 h at the time of SlCr labeling. "No peptide" controls were always in- 
dude& AlL except Ross and Blair (P. troglodytes), are P. paniscus B cell lines. 
5Three separate experiments were conducted. 
alleles  could account for all but one heavy chain band ob- 
served  on  1D-IEF gels  (Fig.  1).  We  anticipate  this  class  I 
heavy chain to represent a Papa-B allele, on the basis ofim- 
munoprecipitations  with  mAbs  ME1  and  4E  (data  not 
shown),  because of their specificity for -B allotypes in the 
HLA system (16,  17). 
The class I heavy chain sequence encoded by the Kidogo 
A1  allele  (Papa-A06)  has  only two  amino acid differences 
from Parr-A04 in the peptide binding site domains.  Addi- 
tionally,  the  inferred  Papa-A06 mature  protein  has  a pre- 
dicted  isoelectric  point  compatible  with  the  unique  posi- 
tion of the Kidogo A1 heavy chain band on the 1D-IEF gel 
(Fig.  3).  This  further  strengthened  the  candidacy  of the 
Papa-A06  class  I  molecule  for  presentation  of  p206bc. 
Peptide p206bc Titration 
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Figure 2.  CTL assay using CTL fine 503/11.3 against Kidogo (P. pa- 
niscus) and Ross (P. troglodytes) BLCL targets. BLCL targets fimm  R.oss ([--1) 
and Kidogo (0)  were  sensitized with  the  indicated concentration of 
p206bc for 1 h during labeling with 50 IxCi of SlCr. After three washes, 
targets were incubated for 4 h with CTL line 503/11.3 at an E/T ratio of 
20:1. 
Combined  with  these  data  and  the  fact that  the  p206bc- 
presenting class I molecule of R.oss and Blair was also an -A 
allotype, we set out to test the hypothesis that the Papa-A06 
allotype was presenting p206bc to the CTL line 503/11.3. 
Clones verified to be free of PCR-induced errors were 
obtained (14),  and a series of single-allele  transfectants was 
established. Kidogo A1 (and A2) and Patr-A04 cDNA were 
transfected  into  the  class  1-negative mutant  human B  cell 
line  LCL 721.221  (12).  Cell surface class  I  expression was 
confirmed  by  flow  cytometry  using  the  fluorescently  la- 
beled mAb W6/32,  and the  authenticity  of the  expressed 
alleles  was confirmed by further immunoprecipitation  and 
1D-IEF  analysis.  The  transfected  cells  were  sorted  by 
FACS  |  and  tested  for  the  capacity  to  present  p206bc  to 
CTL line 503/11.3  (Table 2). Transfectants expressing Ki- 
dogo A1 and Patr-A04 were lysed in the presence but not 
in the absence ofp206bc, whereas the transfectant express- 
ing Kidogo A2, like nontransfected 721.221  cells,  was not 
lysed. The specific lysis  of both the Kidogo A1- and Patr- 
A04-expressing  transfectants  by  CTL line  503/11.3  con- 
firmed the  cross-species presentation  of peptide  206bc  by 
these two allotypes. 
The Kidogo A1 allele possesses  highest homology (~98%) 
with  Patr-A04.  There  are  nine  nucleotide  differences,  six 
coding  (nucleotides  13,28,256,269,872,988)  and  three 
noncoding  (Table  3).  Of  the  resulting  six  amino  acid 
changes, only two occur in the peptide binding cleft; both 
are in the  o~1  domain  at  residues  62  and  66.  The or2  do- 
mains are identical.  Crystallographic analysis of class I mol- 
ecules  (5)  demonstrated that the peptide-binding  cleft was 
formed by the ~1  and er  extracellular  domains  and  con- 
tained  up  to six definable  subsites  (pockets A-+F)  that in- 
teract with the side chains of bound peptides  (6).  Extrapo- 
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Mutant Ceil Line LCL 721.221  by CTL Line 503/11.3 
Table 3.  Posit~nsofSequen~Diffe~n~  between Kidogo A1 
and Patr-A04 
Percentage of  Lysisofmrgetsby 
CTL line503/ll.3* 
Target cell  p206bc*  20:l  5:1  1:1 
LCL 721.221  -  3  1  2 
+  4  2  2 
Patr-A04.221  -  0  0  0 
+  83  68  31 
Kidogo A1.221  -  3  0  0 
+  93  78  40 
Kidogo A2.221  -  2  2  2 
+  6  2  0 
Nucleofide 
Exonl  Exon2  Exon3  Exon4  Exon5 
13  24  28  256  269  498  538  872  988 
KidogoA1  C  T  C  C  A  T  T  T  A 
Patr-A04  G  C  G  G  G  C  C  C  G 
Amino acid  -20  -15  62  66  267  306 
KidogoA1  P  L  Q  N  L  M 
Patr-A04  A  V  E  S  P  V 
Protein 
domain  Leader sequence  0tl  0t2  cx3  TMD 
*Target cells  were incubated with CTL line 503/11.3  at the indicated 
E/T ratios for 4 h, when 100 bd ofsupernatant was collected for count- 
ing in an isomedic gamma counter (ICN, Irvine, CA). Values represent 
a percentage of specific 5~Cr release. 
*Target cells  were untreated or sensitized with a 10-p.M concentration 
ofp206bc for 1 h during labeling with 50 IxCi  of SlCr. 
lation from those structures suggests that residue 62 would 
not interact with  either p206bc  or the  TCR  of CTL line 
503/11.3.  Residue  66  is  a  polymorphic  position,  and  its 
side chain is expected to contribute to the rim of the A  and 
B  pockets. The  demonstration that the Kidogo A1  mole- 
cule binds and efficiently presents p206bc indicates that the 
serine-to-asparagine substitution at position 66 neither dis- 
rupts peptide binding nor T  cell recognition. In contrast to 
Kidogo A1, Kidogo A2 is more  divergent from Patr-A04. 
Figure 3.  1D-IEF analysis of pygmy chimpanzee MHC class I mole- 
cule heavy chains. Isoelectric focusing gel of Papa (Bosondjo, Brian, Jill, 
Kanzi, Kitty, Kidogo, Laura, Lord, Matata, Panbanisha, Zalia), Patr (Blair 
458, Ross 503), and HLA (Jesthom) -A, -B, and -C class I heavy chains. 
Class I molecules were precipitated by the mouse mAb W6/32 from bio- 
synthetically radiolabeled B  cell lines. Sequential immunoprecipitations 
with two mAbs, ME1 and 4E, that partially deplete -B and -C class I mol- 
ecules preceded the W6/32 precipitation (not shown). Extensive sharing 
of class I heavy chain bands reflects familial relationships in this group of 
pygmy chimpanzees. This W6/32 immunoprecipitation clearly indicates 
that the Kidogo A1 heavy chain band is not shared by any of the other 
pygmy chimpanzees, or by either of the two common  chimpanzee cell 
fines, Ross and Blair, that possess  Patr-A04. 
Only amino  acid-replacing  (nonsynonymous)  substitutions  are  indi- 
cated; binding site replacement  substitutions are indicated in boldface 
(single-letter code).  The peptide-binding site is composed  of the  cd 
and or2 domains. 
TMD, transmembrane domain. 
Kidogo A2 has 21  nucleotide differences and 7 binding site 
amino  acid differences compared with  Patr-A04,  showing 
higher homology with Patr-A1  and inferring selection of a 
different peptide repertoire. Therefore  the structural simi- 
larity between the Kidogo A1 and Patr-A04 class I aUotypes 
is entirely consistent with the results of the functional ex- 
periments,  indicating  their  capacity  to  present  the  same 
peptide to the same TCR.  This does not imply, however, 
that the peptide selection preference of each of the two al- 
lotypes is  necessarily identical.  It is possible, for  example, 
that the structural difference could bring about differential 
binding affinities for given peptides. This issue has not been 
explored in these experiments. 
That two primate species with related (to each other and 
to  the  HLA-A3/A9/A80 hneage)  but not identical MHC 
class I alleles preserve a given peptide/TCR  specificity is of 
considerable  interest.  This  had  previously  been  docu- 
mented for MHC  class II alleles when the macaque DRB103 
molecule  was  demonstrated  to  present  a  mycobacterial 
heat-shock  peptide  to  a  human  T  cell line  restricted by 
HLA-DR17  (18).  However, this is the first time that cross 
species presentation by a class I molecule has been demon- 
strated. This finding implies that other antigens might also 
act as epitopes for class I molecules/TCR across other pri- 
mate  species, including humans.  This  is further  supported 
by the observation that some ape and human  class I  mole- 
cules share  identical pocket structures,  for example,  the  F 
pocket  of Patr-A04,  Kidogo  A1,  and  HLA-A0301.  That 
we  have  observed this phenomenon  in  a  group  of mosdy 
related  (all  except  two)  pygmy  chimpanzees,  and  with  a 
small sample  size  of both  alleles and  CTL  lines,  suggests 
that cross-reactivity could occur with significant frequency. 
The  relative  contributions  of disease-specific selection, 
genetic  drift,  and  frequency-dependent  selection  for  het- 
erozygosity in driving evolution at MHC  class I loci remain 
666  Cross-Species Presentation of a Hepatitis C Viral Peptide conjectural.  On the basis of current  1D-IEF and sequence 
data  (albeit obtained from a  captive population),  Patr-A04 
appears  to  be  a  common  allele  in  P.  troglodytes. It is  also 
more closely related to the Kidogo A1  allele in P. paniscus 
than  to  any  of the  other  six  Papa-A  alleles  currently  se- 
quenced.  Of the  nine  nucleotides  that distinguish  Kidogo 
A1  from  Patr-A04  (Table  3),  six  are  nonsynonymous 
(amino acid replacing) substitutions.  However, only two of 
the six amino acid differences occur in the antigen-binding 
site and, putatively,  only one of the two is a peptide  con- 
tact residue.  This pattern  of substitution  contrasts with the 
higher rate of substitution  that occurs "inside" the antigen- 
binding site of classical class I  molecules  (6,  7).  The possi- 
bility therefore  arises that,  within  the  time frame of diver- 
gence between these two alleles (at least 2 million yr), there 
has been selection for the preservation of a peptide specific- 
ity. There is no evidence for HCV as a pathogen for either 
chimpanzee species in the wild, but this does not preclude 
the  existence  of the  p206bc  (or  highly  homologous)  se- 
quence  arising by proteolytic processing of another related 
type  II RNA  viral protein  or from some  other  pathogen 
carrying this sequence. 
P. troglodytes and P. paniscus live in geographically distinct 
habitats,  separated  by the  Zaire  River,  the  oldest  natural 
barrier in the  region,  with  P.  troglodytes to the  north  rela- 
tively euryoecious,  occupying an  area at least  an  order  of 
magnitude  greater  and  with  more  diverse  environmental 
demands (19). P. paniscus cohabits the Zaire basin with dif- 
ferent  branches  of the  Mongo  tribe,  though  we  are  un- 
aware  of chronological  estimates  of this  cohabitation  or 
specific details of the major environmental pathogens of the 
region. Leprosy ("bakechi") is known to afflict this human 
forest population,  and  leprotic-like  lesions  have been  ob- 
served  in  pygmy chimpanzees  at  the  Wamba  site  (19).  A 
number of "natural" pathogens are shared by man and apes, 
including Mycobacterium leprae, and the cross-species presen- 
tation by MHC  class  II molecules reported by Geluk et al. 
(18) involved preservation of the ability to present a myco- 
bacterial hsp65 peptide.  Further comparison between these 
two  African  ape  species,  so  closely  related  genetically  to 
humans,  could  strengthen  evidence  supporting  a  mecha- 
nism of disease-specific selection on MHC  allotype peptide 
specificities. It allows analysis of the nature, sites, and distri- 
bution ofpolymorphisms in relation to presentation of spe- 
cific antigens over time. 
These  data  are  entirely  compatible  with  recent  reports 
indicating  shared  peptide  specificities  between  groups  of 
related  human  class  I  allotypes  (20)  and  contribute  to  an 
emerging understanding  of rules influencing peptide selec- 
tion  by  class  I  molecules.  This  is potentially  encouraging 
for peptide-based vaccine development programs and per- 
haps  for  human  vaccine  development  programs  using 
higher primates. 
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